Plasma AR and abiraterone-resistant prostate cancer A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ... Science translational medicine 7 (312), 312re10-312re10, 2015 | 477 | 2015 |
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution … V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ... Annals of Oncology 28 (7), 1508-1516, 2017 | 284 | 2017 |
Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer HI Scher, RP Graf, NA Schreiber, A Jayaram, E Winquist, B McLaughlin, ... JAMA oncology 4 (9), 1179-1186, 2018 | 241 | 2018 |
Prostate-specific antigen decline after 4 weeks of treatment with abiraterone acetate and overall survival in patients with metastatic castration-resistant prostate cancer P Rescigno, D Lorente, D Bianchini, R Ferraldeschi, MP Kolinsky, ... European urology 70 (5), 724-731, 2016 | 91 | 2016 |
Plasma androgen receptor and docetaxel for metastatic castration-resistant prostate cancer V Conteduca, A Jayaram, N Romero-Laorden, D Wetterskog, S Salvi, ... European urology 75 (3), 368-373, 2019 | 87 | 2019 |
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test E Gonzalez-Billalabeitia, V Conteduca, D Wetterskog, A Jayaram, ... Prostate cancer and prostatic diseases 22 (2), 195-205, 2019 | 60 | 2019 |
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus … N Romero-Laorden, R Lozano, A Jayaram, F López-Campos, MI Saez, ... British Journal of Cancer 119 (9), 1052-1059, 2018 | 43 | 2018 |
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data D Kleftogiannis, M Punta, A Jayaram, S Sandhu, SQ Wong, ... BMC Medical Genomics 12, 1-12, 2019 | 11 | 2019 |
Managing metastatic castration-resistant prostate cancer in the pre-chemotherapy setting: a changing approach in the era of new targeted agents Z Zafeiriou, A Jayaram, A Sharp, JS de Bono Drugs 76, 421-430, 2016 | 11 | 2016 |
Cabozantinib—getting under the skin of cutaneous toxicity A Jayaram, Z Zafeiriou, JS de Bono JAMA oncology 1 (4), 535-536, 2015 | 11 | 2015 |
Plasma DNA and metastatic castration-resistant prostate cancer: The odyssey to a clinical biomarker test A Jayaram, D Wetterskog, G Attard Cancer Discovery 8 (4), 392-394, 2018 | 9 | 2018 |
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) alone or in combination with abiraterone (AA) in patients (pts) with … A Jayaram, K Nowakowska, J Mateo, T Hernandez, S Kumar, B Fulton, ... Annals of Oncology 28, vii30, 2017 | 5 | 2017 |
Diagnostic Gleason score and castration-resistant prostate cancer A Jayaram, G Attard Annals of Oncology 27 (6), 962-964, 2016 | 4 | 2016 |
Cabazitaxel—a key therapeutic option in prostate cancer A Jayaram, G Attard Nature Reviews Urology 12 (6), 312-313, 2015 | 4 | 2015 |
Association between PSA declines at 4 weeks and OS in patients treated with abiraterone acetate (AA) for metastatic castration resistant prostate cancer (mCRPC) after docetaxel. P Rescigno, D Lorente, R Ferraldeschi, D Bianchini, S Sideris, Z Zafeiriou, ... Journal of Clinical Oncology 33 (7_suppl), 215-215, 2015 | 3 | 2015 |
Clinical qualification of plasma androgen receptor (pAR) status and outcome on abiraterone acetate (AA) plus prednisone or dexamethasone (+P/D) in a phase II … A Jayaram, A Wingate, MTA Sharabiani, D Wetterskog, F Calabro, ... Journal of Clinical Oncology 36 (15_suppl), 5067-5067, 2018 | 1 | 2018 |
Phase II study of prednisone-dexamethasone switch in metastatic castration resistant prostate cancer (mCRPC) patients treated with abiraterone and prednisone (AA+ P) RL Mejorada, NR Laorden, A Jayaram, F López, MI Sáez, R Villatoro, ... Annals of Oncology 28, v276, 2017 | | 2017 |